glp-1 drugs for weight loss insurance coverage Employers Take a Variety of Approaches to Metabolic surgery and GLP-1 agonists

Most patients might likely be focused only on weight reduction and stay oblivious to other metabolic and disease protection benefits

[DOI] [PubMed] [Google Scholar] 79.Liraglutide and cardiovascular outcomes in type 2 diabetes

While the FDA recently approved the first generic version of Victoza , or liraglutidea first-generation GLP-1 that has been on the FDA's shortage list since 2023demand for the once-daily injection has waned as patients move to more effective once-weekly treatments like Ozempic and Mounjaro

Those taking tirzepatide, managed an additional 5.5% WL from randomisation, compared to those taking placebo who experienced mean weight regain of 14% from randomisation [49]

Tang X, Shi Y, Chen Y, Sun Z, Wang L, Tang P, et al